Description

The session will include an evaluation of how treatment with new linear accelerators with very high dose rates using flattening free filters may result in different outcomes, especially with stereotactic body radiotherapy. It will also include updates on the newest studies relating to the use of hypofractionated radiotherapy in the treatment of breast and prostate cancers.

Subspecialties: NIS, RO
Modalities: MO

Speaker(s):

• Matthew Abramowitz, MD
• Indrin Chetty, PhD
• Gary Freedman, MD
• Andre Konski, MD, MBA
• Jacqueline Williams, PhD

Disclosures

• Honorarium and Travel Expenses for non ACR events  from Varian Medical Systems and US Oncology
• Consultant: GE Healthcare; Honoraria and Research Grants: Elekta
• Research Grants: Phillips Healthcare and Varian Medical Systems